Thalidomide: An Overview of its Pharmacological Mechanisms of Action
Journal:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume:
5
Page:
71-77
Author(s):
Elizabeth P. Sampaio, Daniel S. Carvalho, Jose A. C. Nery, Ulisses G. Lopes and Euzenir N. Sarno
Anti-Cancer Therapy: Targeting the Mevalonate Pathway
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
15-37
Author(s):
Kelly M. Swanson and Raymond J. Hohl
The Stem Cell Factor Receptor/c-Kit as a Drug Target in Cancer
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
65-75
Author(s):
J. Lennartsson and L. Ronnstrand
Disruption of Metabolic Pathways - Perspectives for the Treatment of Cancer
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
77-87
Author(s):
Eliana P. Araujo, Jose B. Carvalheira and Licio A. Velloso
New Targets, New Agents, and the Evolving Phenomena of Drug Resistance in Cancer
Journal:
Current Cancer Therapy Reviews
Volume:
2
Page:
23-30
Author(s):
Shi-Ping Luh and Moulay A. Alaoui-Jamali
YB-1 Activities in Oncogenesis: Transcription and Translation
Journal:
Current Cancer Therapy Reviews
Volume:
2
Page:
31-39
Author(s):
Andreas G. Bader
STAT Inhibition in the Treatment of Cancer: Transcription Factors as Targets for Molecular Therapy
Journal:
Current Cancer Therapy Reviews
Volume:
2
Page:
57-65
Author(s):
David A. Frank
Tumor Control by Manipulation of the Human Anti-Apoptotic Survivin Gene
Journal:
Current Cancer Therapy Reviews
Volume:
2
Page:
73-79
Author(s):
Zakir Khan, Pratiksha Bhadouria, Radha Gupta and Prakash S. Bisen
Recent Clinical Trials in Non-Small Cell Lung Cancer
Journal:
Current Cancer Therapy Reviews
Volume:
2
Page:
81-99
Author(s):
Suresh Ramalingam and Chandra P. Belani
Targeting Transcription Factors for Cancer Gene Therapy
Journal:
Current Gene Therapy
Volume:
6
Page:
17-33
Author(s):
Towia A. Libermann and Luiz F. Zerbini